Sumiseki HoldingsInc Dirección
Dirección controles de criterios 0/4
Actualmente no disponemos de información suficiente sobre el CEO.
Información clave
Shosuke Mori
Chief Executive Officer (CEO)
n/a
Compensación total
Porcentaje del salario del CEO | n/a |
Permanencia del CEO | less than a year |
Participación del CEO | 0.04% |
Permanencia media de la dirección | sin datos |
Promedio de permanencia en la Junta Directiva | less than a year |
Actualizaciones recientes de la dirección
Recent updates
Investors Shouldn't Overlook Sumiseki HoldingsInc's (TSE:1514) Impressive Returns On Capital
Oct 08The Market Doesn't Like What It Sees From Sumiseki Holdings,Inc.'s (TSE:1514) Earnings Yet As Shares Tumble 28%
Aug 02Does Sumiseki HoldingsInc (TSE:1514) Deserve A Spot On Your Watchlist?
Jul 24Why Investors Shouldn't Be Surprised By Sumiseki Holdings,Inc.'s (TSE:1514) 31% Share Price Plunge
Jun 17Sumiseki HoldingsInc's (TSE:1514) Earnings Offer More Than Meets The Eye
May 22Investors Give Sumiseki Holdings,Inc. (TSE:1514) Shares A 31% Hiding
Apr 17With EPS Growth And More, Sumiseki HoldingsInc (TSE:1514) Makes An Interesting Case
Mar 19CEO
Shosuke Mori (65 yo)
less than a year
Permanencia
Mr. Shosuke Mori is Chairman of Sumiseki Holdings,Inc. and has been its President & Representative Director since June 2024 and serves as its Director since June 2023. Mr. Mori joined the Sumiseki Holdings...
Miembros de la Junta
Nombre | Posición | Permanencia | Compensación | Propiedad |
---|---|---|---|---|
President & Chairman | 1.4yrs | sin datos | 0.038% ¥ 17.0m | |
Executive Officer | less than a year | sin datos | 0.016% ¥ 7.3m | |
Independent Outside Director | less than a year | sin datos | sin datos | |
Director | less than a year | sin datos | sin datos | |
Independent Outside Director | less than a year | sin datos | sin datos |
0.4yrs
Permanencia media
60yo
Promedio de edad
Junta con experiencia: La junta directiva de 1514 no se considera experimentada (0.4 años de permanencia promedio), lo que sugiere una nueva junta directiva.